Neurodegeneration

John Lukens directs UVA’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases and a new study reveals that blocking an immune system molecule in mice prevented memory loss and other signs of mental decline.

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially less likely to develop the memory-robbing condition. The researchers, led by UVA’s Jayakrishna Ambati, MD, previously identified a possible mechanism by which the drugs could prevent […]

UVA Health researchers say drugs used to treat HIV could help prevent a million new cases of Alzheimer’s each year – and they want clinical trials to find out.

The effort raised more than $70,000 to support UVA’s Alzheimer’s research and patient care.

Jim Ryan is also dedicating funds raised from Monday’s race to support UVA patients battling the disease.

Dr. Anelyssa D’Abreu talked with UVA Today about ways people can reduce their risk of developing dementia, most often linked to Alzheimer’s disease.

Lulu Jiang, MD, PhD, an assistant professor in the Department of Neuroscience at UVA School of Medicine, was awarded a $3.6 million R01 grant from the National Institute on Aging for her project titled “Epitranscriptomic Mechanism in the Pathogenesis of Alzheimer’s Disease.” Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting over 6 million people […]

UVA researchers’ laboratory findings could be life-changing for those suffering from neurodegenerative diseases. Funding from UVA’s Brain Institute will help them take their research to the next level.